ICAD Inc
NASDAQ:ICAD

Watchlist Manager
ICAD Inc Logo
ICAD Inc
NASDAQ:ICAD
Watchlist
Price: 1.78 USD 5.64% Market Closed
Market Cap: 47.2m USD
Have any thoughts about
ICAD Inc?
Write Note

ICAD Inc
Investor Relations

iCAD, Inc. is a medical technology company, which engages in the provision cancer detection and therapy solutions. The company is headquartered in Nashua, New Hampshire and currently employs 136 full-time employees. The firm operates through two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). In the Detection segment, the Company’s solutions include advanced image analysis and workflow solutions enables healthcare professionals to serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, and a comprehensive range of artificial intelligence and computer aided detection (CAD) systems and workflow solutions for two-dimension(2D) and third dimension (3D) mammography, magnetic resonance imaging (MRI) and computed tomography (CT). In the Therapy segment, the Company offers the Xoft System, an isotope-free cancer treatment platform technology. The Xoft System can be used for the treatment of early-stage breast cancer, endometrial cancer, cervical cancer and nonmelanoma skin cancer.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Ms. Dana R. Brown
President, CEO & Executive Chair
No Bio Available
Mr. Eric Lonnqvist
Chief Financial Officer
No Bio Available
Mr. Jonathan Go
Chief Technology Officer
No Bio Available
Ms. Michelle Strong
Chief Operations Officer
No Bio Available
Ms. Annette L. Heroux
Vice President of Administration
No Bio Available
Brian Testa
Chief People Officer
No Bio Available
Mr. Bill Keyes
Senior VP of Global Sales Operations
No Bio Available
Mr. Vasu Avadhanula
Chief Product Officer
No Bio Available
Mr. Peter Graham
Senior VP of North American Sales
No Bio Available

Contacts

Address
NEW HAMPSHIRE
Nashua
98 Spit Brook Rd Ste 100
Contacts
+16038825200.0
www.icadmed.com